Information for Medical Trainees

Hematology Residency Training Program

The Hematology Residency Training Program is proud to provide an extremely strong training experience that is fully accredited by the Royal College of Physicians and Surgeons of Canada. The residents that complete our program have a sound knowledge base and become competent and self reliant hematologists after a two year training program.

Our program benefits from having a strong Bone Marrow Transplant Program (in particular, a second-to-none inter-disciplinary team providing innovative, high quality, ethical and empathic care) as well as an internationally renowned Thrombosis Program with world-class research funding and productivity. Few programs in the country can boast strengths in both these content areas of clinical hematology (malignant hematology and thrombosis) and these two important aspects of academic life (patient care and research). We provide a great degree of flexibility in the Residency Training Program in order to meet the career needs of our candidates, with up to 8 months of elective time for each resident to individualize their program based on their particular interest in the field (research, education, subspecialties).

The division is extremely supportive of the Hematology Training Program with a strong commitment to education and the CanMEDS philosophy. At the completion of each of the rotations, residents are evaluated based on the CanMEDS framework set forth by the Royal College. Strengths of our educational program include well-organised weekly academic sessions with faculty involvement, a culture of ongoing formative evaluation and unique longitudinal clinics that teach residents to become independent medical experts in hematology. The best measure of success in our program is the success of our graduates. Our graduates have done well in their RCPS examinations and have established successful careers in a wide variety of areas from careers in community hematology to basic scientists in leukemia research.

 

Thrombosis Fellowship Program

The Thrombosis Clinical Fellowship program of the Division of Hematology at the University of Ottawa is based in an active, academic, tertiary care subspecialty service. The Thrombosis Program and its members are engaged in a wide variety of innovative clinical and research activities in the areas of (1) Diagnosis and treatment of venous and arterial thromboembolic disease and (2) Management of thrombophilia. Areas of research activity include basic science, clinical health, economic and outcomes research.

The objectives of the Clinical Fellowship are to train high level specialists in thrombosis. The fellows are expected to develop an in-depth knowledge of the physiology, pathology, diagnosis and treatment of thrombotic diseases through a variety of activities, including direct inpatient and outpatient care, clinical and basic research and other academic activities.

The Thrombosis Program at the Ottawa Hospital runs daily Thrombosis Clinics (365 days/year) with referrals from Ottawa and surrounding communities. There are approximately 13,000 visits per year for investigation or treatment for venous thrombosis, thrombophilia or anticoagulation management. In addition, we provide consult service to > 1000 in-patients at 2 campuses of the Ottawa Hospital (~1000 patient beds). The expectation is that at the end of training you will be able to perform as an expert thrombosis consultant.

Educational and Training Objectives

The general objective for the fellows is to acquire clinical skills pertaining to the diagnosis and treatment of thrombotic diseases including but not limited to diagnosis (clinical, lab and imaging) of deep vein thrombosis, pulmonary embolism, other thrombotic disease, thrombophilia (acquired and genetic) and peri-operative anticoagulation.

Specific objectives are to demonstrate expertise in:

  • The use of spiral CT scan for the diagnosis of PE, VQ scan for the diagnosis of PE, ultrasound for the diagnosis of DVT, Spiral CT and venography.
  • Laboratory and clinical diagnosis and management implications of Protein C, S and AT deficiency, Factor V Leiden, Prothrombin Gene variant, Hyperhomocysteinemia and Antiphospholipid antibody syndrome.
  • Laboratory diagnosis and clinical management of HIT.
  • Known indications, complications and limitations for IVC filters ‚Äď permanent and retrievable.
  • Duration of anticoagulation for thrombotic disease including DVT and PE.
  • The diagnosis and therapeutic management of mesenteric vein thrombosis, cerebral sinus thrombosis, central retinal artery and central retinal vein occlusion.
  • The diagnosis and management of thromboembolism in pregnancy.
  • The diagnosis, risk stratification and anticoagulation for atrial fibrillation, peripheral arterial disease and stroke.
  • Order to counsel patients on birth control and thrombosis and hormone replacement therapy and thrombosis.
  • Anticoagulant medications, including reversal of anticoagulation (indications and tools), Warfarin dosing induction and maintenance, and the role of thrombolytics for pulmonary embolism and deep vein thrombosis,
  • Post-phlebitic syndrome, diagnosis and management.
  • Diagnosis and management of heparin allergies and warfarin allergies.

Evaluation Criteria

The fellows will be evaluated on the basis of their accomplishment of the objectives outlined above using a daily appraisal of the fellow’s skills as well as a formal appraisal of the academic activities in which he will be involved (i.e. rounds).

In order to standardize evaluations for trainees within the Division of Hematology, Thrombosis Fellows will be evaluated using the electronic One45 system through the University of Ottawa. Evaluations for outpatient clinics will occur every 6 months and for in-patient services will be completed monthly. Individual meetings with Thrombosis Fellows will take place every 6 months to review and discuss the evaluations.

At the end of the fellowship clinical fellows should be able to:

  • Describe the physiology and pathophysiology of the thrombotic diseases as well as the conditions leading to their development, including in-depth knowledge of thrombophilic states.
  • Describe the clinical characteristics and the key aspects for diagnosis of thrombotic diseases. The fellow is expected to adequately order and interpret all diagnostic studies for thrombotic diseases.
  • Provide adequate treatment and follow up to patients with thrombotic diseases.
  • Describe and provide advice on the prognosis and complications of thrombotic diseases.
  • Describe the epidemiological aspects of thrombotic diseases.
  • Interact with and provide advice to other medical specialists regarding thrombotic diseases in different fields of medicine.

 

Malignant Hematology Fellowship Program

  • PROGRAM DIRECTOR: Dr. Andrea Kew
  • PROGRAM COORDINATOR: Alycia-Anne Martin

 < More info coming soon >

 

CONTACT US

Hematology Residency Thrombosis Fellowship  Malignant Hematology Fellowship 
Program Director  Dr. Dimitri Scarvelis  Dr. Marc Carrier  Dr. Andrea Kew
Email  dscarvelis@toh.ca  mcarrier@toh.ca  akew@toh.ca
Telephone  (613) 737-8899 x 71059  (613) 737-8899 x 73034  (613) 737-8899 x 71281
Assistant  Bonnie Legare  Cathy McSheffery  Cindy Brassard

 

Education Coordinator: Alycia-Anne Martin